Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Tolazoline | hsa00030 | Pentose phosphate pathway | 1.13E-04 | 4 | P60891, P51854, P11413, P37837 | PRPS1, TKTL1, G6PD, TALDO1 | More | | Tolazoline | hsa00480 | Glutathione metabolism | 1.35E-02 | 1 | P11413 | G6PD | More | | Tolazoline | hsa00500 | Starch and sucrose metabolism | 2.15E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Tolazoline | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Tolazoline | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Tolazoline | hsa00531 | Glycosaminoglycan degradation | 8.18E-04 | 2 | P15586, P34059 | GNS, GALNS | More | | Tolazoline | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 2.92E-02 | 1 | Q9Y2C2 | UST | More | | Tolazoline | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Tolazoline | hsa00830 | Retinol metabolism | 4.25E-02 | 1 | P00325 | ADH1B | More | | Tolazoline | hsa00970 | Aminoacyl-tRNA biosynthesis | 5.30E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Tolazoline | hsa01200 | Carbon metabolism | 2.23E-02 | 4 | P51854, P11413, P37837, P60891 | TKTL1, G6PD, TALDO1, PRPS1 | More | | Tolazoline | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | | Tolazoline | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | | Tolazoline | hsa03008 | Ribosome biogenesis in eukaryotes | 2.06E-02 | 2 | Q9NYH9, Q9BVP2 | UTP6, GNL3 | More | | Tolazoline | hsa03013 | RNA transport | 4.09E-02 | 9 | P52298, Q09161, O14893, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Tolazoline | hsa03015 | mRNA surveillance pathway | 1.37E-03 | 6 | Q13362, Q14738, O94913, Q9UBU9, Q9H307, Q13148 | PPP2R5C, PPP2R5D, PCF11, NXF1, PNN, TARDBP | More | | Tolazoline | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Tolazoline | hsa04014 | Ras signaling pathway | 4.37E-03 | 10 | P31751, P42338, P20827, P49767, Q13009, Q7LDG7, P0DP23, P63218, P50151, P19174 | AKT2, PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, CALM1, GNG5, GNG10, PLCG1 | More | | Tolazoline | hsa04015 | Rap1 signaling pathway | 2.75E-03 | 10 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P31751, P0DP23, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, AKT2, CALM1, PLCG1 | More | | Tolazoline | hsa04020 | Calcium signaling pathway | 1.39E-02 | 4 | P30679, O15399, P07550, P23634 | GNA15, GRIN2D, ADRB2, ATP2B4 | More | | Tolazoline | hsa04022 | cGMP-PKG signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Tolazoline | hsa04024 | cAMP signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Tolazoline | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.91E-02 | 6 | P09341, P25024, P25025, P47992, Q9UBD3, P01375 | CXCL1, CXCR1, CXCR2, XCL1, XCL2, TNF | More | | Tolazoline | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Tolazoline | hsa04064 | NF-kappa B signaling pathway | 7.66E-06 | 14 | P10415, Q13489, P25963, P51617, O00463, Q13546, P01375, Q04759, Q9UDY8, Q13077, Q16548, Q13315, P24522, Q9UNE0 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, RIPK1, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, ATM, GADD45A, EDAR | More | | Tolazoline | hsa04071 | Sphingolipid signaling pathway | 3.74E-04 | 7 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Tolazoline | hsa04080 | Neuroactive ligand-receptor interaction | 3.10E-05 | 12 | P08311, P28472, Q15722, P21453, Q9H228, P43657, O00398, P21462, P21730, P14416, P07550, P35318 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, FPR1, C5AR1, DRD2, ADRB2, ADM | More | | Tolazoline | hsa04114 | Oocyte meiosis | 1.25E-03 | 7 | P51812, Q02750, P0DP23, P16298, Q17RY0, Q13362, Q14738 | RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, PPP2R5C, PPP2R5D | More | | Tolazoline | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Tolazoline | hsa04120 | Ubiquitin mediated proteolysis | 3.42E-03 | 6 | Q14145, Q13042, P30260, Q13191, P62837, Q15751 | KEAP1, CDC16, CDC27, CBLB, UBE2D2, HERC1 | More | | Tolazoline | hsa04142 | Lysosome | 1.14E-02 | 3 | P43234, P15586, P34059 | CTSO, GNS, GALNS | More | | Tolazoline | hsa04145 | Phagosome | 1.98E-02 | 8 | Q15080, P14598, Q13509, Q13488, P05164, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Tolazoline | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Tolazoline | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Tolazoline | hsa04152 | AMPK signaling pathway | 1.83E-02 | 3 | Q96RR4, Q13362, Q14738 | CAMKK2, PPP2R5C, PPP2R5D | More | | Tolazoline | hsa04210 | Apoptosis | 1.42E-03 | 12 | Q13315, P04637, P10415, Q13489, P25963, P01375, P24522, Q16548, Q13077, P43234, Q14643, P63261 | ATM, TP53, BCL2, BIRC3, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ITPR1, ACTG1 | More | | Tolazoline | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Tolazoline | hsa04217 | Necroptosis | 1.85E-03 | 7 | P01375, P01568, P48023, Q13489, Q13546, Q14765, Q99878 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT4, H2AC14 | More | | Tolazoline | hsa04218 | Cellular senescence | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Tolazoline | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.26E-04 | 7 | P07550, P22694, P31751, P18848, Q13362, Q14738, P0DP23 | ADRB2, PRKACB, AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Tolazoline | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Tolazoline | hsa04370 | VEGF signaling pathway | 3.03E-04 | 4 | P16298, P31751, Q05397, Q02750 | PPP3CB, AKT2, PTK2, MAP2K1 | More | | Tolazoline | hsa04371 | Apelin signaling pathway | 9.78E-04 | 9 | P63218, P50151, Q8WYR1, P31751, Q14814, Q14344, Q13485, P84022, P0DP23 | GNG5, GNG10, PIK3R5, AKT2, MEF2D, GNA13, SMAD4, SMAD3, CALM1 | More | | Tolazoline | hsa04380 | Osteoclast differentiation | 2.11E-03 | 2 | Q9NQC7, P31751 | CYLD, AKT2 | More | | Tolazoline | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Tolazoline | hsa04612 | Antigen processing and presentation | 5.66E-05 | 8 | P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01375 | RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Tolazoline | hsa04613 | Neutrophil extracellular trap formation | 5.16E-05 | 17 | P17252, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Tolazoline | hsa04620 | Toll-like receptor signaling pathway | 4.81E-03 | 3 | Q13546, P01568, P31751 | RIPK1, IFNA21, AKT2 | More | | Tolazoline | hsa04621 | NOD-like receptor signaling pathway | 7.18E-04 | 13 | Q14643, P01568, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q13546, Q05823, P01375, P49913, P12838 | ITPR1, IFNA21, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RIPK1, RNASEL, TNF, CAMP, DEFA4 | More | | Tolazoline | hsa04622 | RIG-I-like receptor signaling pathway | 1.02E-03 | 3 | P01568, Q9NQC7, Q13546 | IFNA21, CYLD, RIPK1 | More | | Tolazoline | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Tolazoline | hsa04625 | C-type lectin receptor signaling pathway | 1.38E-05 | 3 | Q9NQC7, P31751, P0DP23 | CYLD, AKT2, CALM1 | More | | Tolazoline | hsa04650 | Natural killer cell mediated cytotoxicity | 1.55E-06 | 12 | P16298, P50591, P01375, O60880, P20963, Q02750, Q13241, P26718, O75015, P26717, Q14953, P26715 | PPP3CB, TNFSF10, TNF, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | | Tolazoline | hsa04657 | IL-17 signaling pathway | 1.64E-03 | 8 | O00463, Q16539, P49841, P09341, P19875, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, LCN2, TNF | More | | Tolazoline | hsa04659 | Th17 cell differentiation | 1.70E-02 | 7 | P19174, P14784, P14778, P84022, Q13485, P08238, P07766 | PLCG1, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Tolazoline | hsa04660 | T cell receptor signaling pathway | 4.20E-02 | 7 | P01375, P25963, Q9UDY8, Q04759, P10747, O95267, Q08881 | TNF, NFKBIA, MALT1, PRKCQ, CD28, RASGRP1, ITK | More | | Tolazoline | hsa04662 | B cell receptor signaling pathway | 3.64E-03 | 6 | P31751, P42338, P60033, P07948, P21854, Q8N149 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Tolazoline | hsa04664 | Fc epsilon RI signaling pathway | 7.18E-03 | 5 | P31751, P42338, P07948, P19174, P09917 | AKT2, PIK3CB, LYN, PLCG1, ALOX5 | More | | Tolazoline | hsa04668 | TNF signaling pathway | 2.93E-03 | 9 | P01375, O00463, Q13489, P25963, P18848, P19875, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, NFKBIA, ATF4, CXCL2, BCL3, TRAF1, MMP9 | More | | Tolazoline | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Tolazoline | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Tolazoline | hsa04722 | Neurotrophin signaling pathway | 1.26E-03 | 5 | P31751, P49841, O43524, P48023, P0DP23 | AKT2, GSK3B, FOXO3, FASLG, CALM1 | More | | Tolazoline | hsa04728 | Dopaminergic synapse | 7.72E-04 | 4 | P31751, Q13362, Q14738, P0DP23 | AKT2, PPP2R5C, PPP2R5D, CALM1 | More | | Tolazoline | hsa04740 | Olfactory transduction | 9.46E-04 | 2 | Q9H255, P0DP23 | OR51E2, CALM1 | More | | Tolazoline | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Tolazoline | hsa04744 | Phototransduction | 1.81E-02 | 1 | P0DP23 | CALM1 | More | | Tolazoline | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Tolazoline | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Tolazoline | hsa04914 | Progesterone-mediated oocyte maturation | 2.94E-02 | 3 | Q17RY0, P51812, Q02750 | CPEB4, RPS6KA3, MAP2K1 | More | | Tolazoline | hsa04915 | Estrogen signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Tolazoline | hsa04916 | Melanogenesis | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Tolazoline | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | | Tolazoline | hsa04920 | Adipocytokine signaling pathway | 1.22E-02 | 5 | P25963, P33121, Q04759, P31751, P01375 | NFKBIA, ACSL1, PRKCQ, AKT2, TNF | More | | Tolazoline | hsa04921 | Oxytocin signaling pathway | 3.13E-02 | 3 | P0DP23, Q96RR4, Q13469 | CALM1, CAMKK2, NFATC2 | More | | Tolazoline | hsa04922 | Glucagon signaling pathway | 1.79E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Tolazoline | hsa04923 | Regulation of lipolysis in adipocytes | 3.01E-02 | 1 | P31751 | AKT2 | More | | Tolazoline | hsa04924 | Renin secretion | 6.02E-03 | 3 | P22694, P07550, P0DP23 | PRKACB, ADRB2, CALM1 | More | | Tolazoline | hsa04926 | Relaxin signaling pathway | 2.41E-02 | 4 | P18848, P22694, P14780, P30679 | ATF4, PRKACB, MMP9, GNA15 | More | | Tolazoline | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Tolazoline | hsa04929 | GnRH secretion | 1.81E-02 | 1 | P31751 | AKT2 | More | | Tolazoline | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Tolazoline | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Tolazoline | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Tolazoline | hsa04970 | Salivary secretion | 6.99E-04 | 6 | P07550, P22694, Q14643, P17252, P0DP23, P49913 | ADRB2, PRKACB, ITPR1, PRKCA, CALM1, CAMP | More | | Tolazoline | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Tolazoline | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | | Tolazoline | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Tolazoline | hsa04976 | Bile secretion | 3.87E-02 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | | Tolazoline | hsa04979 | Cholesterol metabolism | 1.61E-02 | 2 | P38571, P61916 | LIPA, NPC2 | More | | Tolazoline | hsa05010 | Alzheimer disease | 8.59E-04 | 3 | Q00535, P0DP23, P31751 | CDK5, CALM1, AKT2 | More | | Tolazoline | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.95E-02 | 2 | Q00535, P0DP23 | CDK5, CALM1 | More | | Tolazoline | hsa05030 | Cocaine addiction | 4.19E-02 | 1 | Q00535 | CDK5 | More | | Tolazoline | hsa05031 | Amphetamine addiction | 6.98E-03 | 4 | P0DP23, P22694, P18848, Q13547 | CALM1, PRKACB, ATF4, HDAC1 | More | | Tolazoline | hsa05033 | Nicotine addiction | 1.22E-02 | 2 | P28472, O15399 | GABRB3, GRIN2D | More | | Tolazoline | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.87E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Tolazoline | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Tolazoline | hsa05132 | Salmonella infection | 2.05E-03 | 14 | P51617, P25963, P01375, Q9UJU2, Q13546, Q13489, P10415, Q96A32, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371 | IRAK1, NFKBIA, TNF, LEF1, RIPK1, BIRC3, BCL2, MYLPF, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C | More | | Tolazoline | hsa05133 | Pertussis | 2.24E-02 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Tolazoline | hsa05140 | Leishmaniasis | 1.59E-03 | 9 | O75015, P14598, P13765, O60603, P25963, P01375, Q16539, P51617, Q15080 | FCGR3B, NCF1, HLA-DOB, TLR2, NFKBIA, TNF, MAPK14, IRAK1, NCF4 | More | | Tolazoline | hsa05143 | African trypanosomiasis | 3.01E-03 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Tolazoline | hsa05144 | Malaria | 1.38E-03 | 4 | O60603, P01375, P35443, P26718 | TLR2, TNF, THBS4, KLRK1 | More | | Tolazoline | hsa05145 | Toxoplasmosis | 3.07E-02 | 7 | P51617, P25963, P01375, P10415, Q13489, P13765, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2 | More | | Tolazoline | hsa05146 | Amoebiasis | 7.83E-05 | 10 | P09341, P19875, P14778, P27930, P01375, O60603, P05089, P30679, P22694, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, ARG1, GNA15, PRKACB, CTSG | More | | Tolazoline | hsa05152 | Tuberculosis | 7.36E-03 | 11 | Q13488, P0DP23, P48382, O60603, P01375, P31751, P10415, P13765, P49913, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, TNF, AKT2, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Tolazoline | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Tolazoline | hsa05161 | Hepatitis B | 2.33E-02 | 8 | P17252, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | | Tolazoline | hsa05163 | Human cytomegalovirus infection | 1.21E-02 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Tolazoline | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.44E-04 | 8 | P31751, P23458, P62879, Q13469, P16298, Q02750, P0DP23, P0CG47 | AKT2, JAK1, GNB2, NFATC2, PPP3CB, MAP2K1, CALM1, UBB | More | | Tolazoline | hsa05170 | Human immunodeficiency virus 1 infection | 2.37E-06 | 20 | P31751, Q02750, P62879, P16298, P0DP23, P01375, Q05397, P17252, O00463, Q14643, P51617, P25963, O60603, Q13315, O95067, P10415, Q13619, Q93034, Q9Y6Q5, P20333 | AKT2, MAP2K1, GNB2, PPP3CB, CALM1, TNF, PTK2, PRKCA, TRAF5, ITPR1, IRAK1, NFKBIA, TLR2, ATM, CCNB2, BCL2, CUL4A, CUL5, AP1M2, TNFRSF1B | More | | Tolazoline | hsa05200 | Pathways in cancer | 1.81E-03 | 19 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P31751, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, AKT2, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IL2RB | More | | Tolazoline | hsa05202 | Transcriptional misregulation in cancer | 1.51E-04 | 14 | Q12778, Q15532, Q13315, P14780, P14923, Q16548, Q13489, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, JUP, BCL2A1, BIRC3, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Tolazoline | hsa05205 | Proteoglycans in cancer | 4.79E-03 | 8 | P63261, P04637, P14780, P01375, P23588, Q06124, Q13635, P22694 | ACTG1, TP53, MMP9, TNF, EIF4B, PTPN11, PTCH1, PRKACB | More | | Tolazoline | hsa05211 | Renal cell carcinoma | 1.47E-03 | 3 | Q06124, Q99814, P31751 | PTPN11, EPAS1, AKT2 | More | | Tolazoline | hsa05212 | Pancreatic cancer | 1.08E-04 | 9 | P42338, P31751, Q15311, P23458, P84022, Q13485, P04637, P24522, O75293 | PIK3CB, AKT2, RALBP1, JAK1, SMAD3, SMAD4, TP53, GADD45A, GADD45B | More | | Tolazoline | hsa05213 | Endometrial cancer | 2.88E-04 | 5 | O15169, P31751, Q02750, P04637, P24522 | AXIN1, AKT2, MAP2K1, TP53, GADD45A | More | | Tolazoline | hsa05214 | Glioma | 1.51E-04 | 4 | P0DP23, P31751, P04637, P24522 | CALM1, AKT2, TP53, GADD45A | More | | Tolazoline | hsa05216 | Thyroid cancer | 1.14E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tolazoline | hsa05217 | Basal cell carcinoma | 2.06E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tolazoline | hsa05218 | Melanoma | 8.68E-04 | 3 | P04637, P31751, P24522 | TP53, AKT2, GADD45A | More | | Tolazoline | hsa05220 | Chronic myeloid leukemia | 1.59E-04 | 9 | Q06124, P04637, Q13547, Q13485, P84022, P31751, P42338, P24522, O75293 | PTPN11, TP53, HDAC1, SMAD4, SMAD3, AKT2, PIK3CB, GADD45A, GADD45B | More | | Tolazoline | hsa05221 | Acute myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Tolazoline | hsa05222 | Small cell lung cancer | 5.10E-03 | 7 | P31751, Q13489, P10415, P25963, Q13077, O00463, P24522 | AKT2, BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Tolazoline | hsa05223 | Non-small cell lung cancer | 1.84E-03 | 3 | P31751, P04637, P24522 | AKT2, TP53, GADD45A | More | | Tolazoline | hsa05224 | Breast cancer | 4.51E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tolazoline | hsa05225 | Hepatocellular carcinoma | 3.30E-02 | 3 | P04637, P24522, P63261 | TP53, GADD45A, ACTG1 | More | | Tolazoline | hsa05226 | Gastric cancer | 4.72E-03 | 3 | Q02750, P31751, O15169 | MAP2K1, AKT2, AXIN1 | More | | Tolazoline | hsa05230 | Central carbon metabolism in cancer | 1.25E-03 | 2 | P31751, P11413 | AKT2, G6PD | More | | Tolazoline | hsa05310 | Asthma | 3.88E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Tolazoline | hsa05321 | Inflammatory bowel disease | 7.13E-04 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Tolazoline | hsa05322 | Systemic lupus erythematosus | 4.20E-02 | 7 | P08246, P08311, P01375, P10747, P13765, Q6FI13, P05455 | ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, SSB | More | | Tolazoline | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Tolazoline | hsa05332 | Graft-versus-host disease | 2.32E-05 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Tolazoline | hsa05415 | Diabetic cardiomyopathy | 3.59E-02 | 1 | P11413 | G6PD | More | | Tolazoline | hsa05418 | Fluid shear stress and atherosclerosis | 6.47E-03 | 8 | Q16539, P31751, P10599, P14780, P01375, P14778, P27930, P0DP23 | MAPK14, AKT2, TXN, MMP9, TNF, IL1R1, IL1R2, CALM1 | More | | |